Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography.

Elkashef AM, Doudet D, Bryant T, Cohen RM, Li SH, Wyatt RJ.

Psychiatry Res. 2000 Nov 20;100(1):1-11.

PMID:
11090720
2.

PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodium.

Yatham LN, Liddle PF, Shiah IS, Lam RW, Ngan E, Scarrow G, Imperial M, Stoessl J, Sossi V, Ruth TJ.

Am J Psychiatry. 2002 May;159(5):768-74.

PMID:
11986130
3.

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.

Hietala J, Syvälahti E, Vuorio K, Räkköläinen V, Bergman J, Haaparanta M, Solin O, Kuoppamäki M, Kirvelä O, Ruotsalainen U, et al.

Lancet. 1995 Oct 28;346(8983):1130-1.

PMID:
7475604
4.

Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study.

Howes OD, Williams M, Ibrahim K, Leung G, Egerton A, McGuire PK, Turkheimer F.

Brain. 2013 Nov;136(Pt 11):3242-51. doi: 10.1093/brain/awt264. Epub 2013 Oct 3.

5.

Disturbed neural circuits in a subtype of chronic catatonic schizophrenia demonstrated by F-18-FDG-PET and F-18-DOPA-PET.

Lauer M, Schirrmeister H, Gerhard A, Ellitok E, Beckmann H, Reske SN, Stöber G.

J Neural Transm (Vienna). 2001;108(6):661-70.

PMID:
11478418
6.

Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study.

Rakshi JS, Uema T, Ito K, Bailey DL, Morrish PK, Ashburner J, Dagher A, Jenkins IH, Friston KJ, Brooks DJ.

Brain. 1999 Sep;122 ( Pt 9):1637-50.

PMID:
10468504
7.

Synthesis and evaluation of an 18F-labeled dopa prodrug as a PET tracer for studying brain dopamine metabolism.

Ishiwata K, Shinoda M, Ishii S, Nozaki T, Senda M.

Nucl Med Biol. 1996 Apr;23(3):295-301.

PMID:
8782240
8.

Modeling of fluorine-18-6-fluoro-L-Dopa in humans.

Wahl L, Nahmias C.

J Nucl Med. 1996 Mar;37(3):432-7.

9.

Dopamine synthesis capacity in patients with treatment-resistant schizophrenia.

Demjaha A, Murray RM, McGuire PK, Kapur S, Howes OD.

Am J Psychiatry. 2012 Nov;169(11):1203-10.

PMID:
23034655
10.
11.

Reproducibility of PET measurement for presynaptic dopaminergic functions using L-[β-(11)C]DOPA and [(18)F]FE-PE2I in humans.

Suzuki M, Ito H, Kodaka F, Takano H, Kimura Y, Fujiwara H, Sasaki T, Takahata K, Nogami T, Nagashima T, Nengaki N, Kawamura K, Zhang MR, Varrone A, Halldin C, Okubo Y, Suhara T.

Nucl Med Commun. 2014 Mar;35(3):231-7. doi: 10.1097/MNM.0000000000000052.

PMID:
24468851
12.

Different corticostriatal patterns of L-DOPA utilization in patients with untreated schizophrenia and patients treated with classical antipsychotics or clozapine.

Gefvert O, Lindström LH, Waters N, Waters S, Carlsson A, Tedroff J.

Scand J Psychol. 2003 Jul;44(3):289-92.

PMID:
12914593
13.

Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.

Antonini A, Vontobel P, Psylla M, Günther I, Maguire PR, Missimer J, Leenders KL.

Arch Neurol. 1995 Dec;52(12):1183-90.

PMID:
7492293
14.

Quality control procedure for 6-[18F]fluoro-L-DOPA: a presynaptic PET imaging ligand for brain dopamine neurons.

Chen JJ, Huang SJ, Finn RD, Kirk KL, Francis BE, Adams HR, Cohen RM, Chiueh CC.

J Nucl Med. 1989 Jul;30(7):1249-56.

15.

Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography.

Danielsen EH, Smith DF, Gee AD, Venkatachalam TK, Hansen SB, Hermansen F, Gjedde A, Cumming P.

Synapse. 1999 Sep 15;33(4):247-58.

PMID:
10421705
16.

Effect of hypoxia/hypercapnia on metabolism of 6-[(18)F]fluoro-L-DOPA in newborn piglets.

Bauer R, Brust P, Walter B, Vorwieger G, Bergmann R, Elhalag E, Fritz A, Steinbach J, Füchtner F, Hinz R, Zwiener U, Johannsen B.

Brain Res. 2002 Apr 26;934(1):23-33.

PMID:
11937066
17.

Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study.

McGowan S, Lawrence AD, Sales T, Quested D, Grasby P.

Arch Gen Psychiatry. 2004 Feb;61(2):134-42.

PMID:
14757589
18.

Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo.

Gründer G, Vernaleken I, Müller MJ, Davids E, Heydari N, Buchholz HG, Bartenstein P, Munk OL, Stoeter P, Wong DF, Gjedde A, Cumming P.

Neuropsychopharmacology. 2003 Apr;28(4):787-94. Epub 2002 Oct 30.

19.

Positron emission tomography in degenerative disorders of the dopaminergic system.

Karbe H, Holthoff V, Huber M, Herholz K, Wienhard K, Wagner R, Heiss WD.

J Neural Transm Park Dis Dement Sect. 1992;4(2):121-30.

PMID:
1571076
20.

Cerebral metabolism of 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine in the primate.

Firnau G, Sood S, Chirakal R, Nahmias C, Garnett ES.

J Neurochem. 1987 Apr;48(4):1077-82.

PMID:
3102690

Supplemental Content

Support Center